Cymat Capex To Depreciation vs Price To Sales Ratio Analysis

CYM Stock  CAD 0.10  0.02  16.67%   
Cymat Technologies financial indicator trend analysis is way more than just evaluating Cymat Technologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cymat Technologies is a good investment. Please check the relationship between Cymat Technologies Capex To Depreciation and its Price To Sales Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cymat Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Capex To Depreciation vs Price To Sales Ratio

Capex To Depreciation vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cymat Technologies Capex To Depreciation account and Price To Sales Ratio. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Cymat Technologies' Capex To Depreciation and Price To Sales Ratio is 0.83. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Cymat Technologies, assuming nothing else is changed. The correlation between historical values of Cymat Technologies' Capex To Depreciation and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of Cymat Technologies are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Capex To Depreciation i.e., Cymat Technologies' Capex To Depreciation and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

0.83
Relationship DirectionPositive 
Relationship StrengthStrong

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Cymat Technologies stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Cymat Technologies sales, a figure that is much harder to manipulate than other Cymat Technologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.
Most indicators from Cymat Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cymat Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cymat Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Enterprise Value is likely to climb to about 22.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 2.6 M in 2024.
 2021 2022 2023 2024 (projected)
Total Revenue3.1M3.1M1.6M1.9M
Depreciation And Amortization177.8K506.6K456.0K668.9K

Cymat Technologies fundamental ratios Correlations

0.180.260.530.440.70.41-0.59-0.350.690.620.74-0.120.650.130.770.310.730.710.630.83-0.220.310.550.01-0.03
0.180.130.67-0.70.420.10.54-0.440.2-0.20.42-0.34-0.17-0.460.290.540.370.280.82-0.090.440.370.430.23-0.28
0.260.130.190.070.3-0.07-0.040.530.340.120.290.690.12-0.03-0.010.220.050.310.250.13-0.02-0.53-0.27-0.710.7
0.530.670.19-0.390.630.30.09-0.360.54-0.010.69-0.150.04-0.380.620.070.650.520.870.190.450.310.46-0.03-0.05
0.44-0.70.07-0.39-0.040.14-0.860.120.230.74-0.10.140.730.60.1-0.130.010.14-0.40.71-0.4-0.07-0.01-0.050.09
0.70.420.30.63-0.040.29-0.02-0.330.760.020.92-0.040.06-0.310.790.440.720.730.760.25-0.180.30.61-0.10.04
0.410.1-0.070.30.140.29-0.25-0.390.530.30.21-0.220.310.130.550.290.440.480.370.42-0.10.410.530.19-0.23
-0.590.54-0.040.09-0.86-0.02-0.250.01-0.38-0.88-0.01-0.04-0.88-0.35-0.260.11-0.1-0.080.14-0.840.35-0.05-0.060.02-0.03
-0.35-0.440.53-0.360.12-0.33-0.390.01-0.3-0.15-0.250.94-0.170.06-0.68-0.38-0.49-0.3-0.49-0.29-0.09-0.98-0.91-0.880.91
0.690.20.340.540.230.760.53-0.38-0.30.380.57-0.020.42-0.120.740.440.630.640.620.53-0.180.370.55-0.08-0.02
0.62-0.20.12-0.010.740.020.3-0.88-0.150.38-0.03-0.111.00.270.240.160.050.080.050.91-0.10.170.190.16-0.14
0.740.420.290.69-0.10.920.21-0.01-0.250.57-0.030.010.01-0.280.750.270.750.720.770.24-0.160.160.48-0.190.15
-0.12-0.340.69-0.150.14-0.04-0.22-0.040.94-0.02-0.110.01-0.120.0-0.42-0.27-0.27-0.04-0.26-0.18-0.14-0.93-0.75-0.980.98
0.65-0.170.120.040.730.060.31-0.88-0.170.421.00.01-0.120.250.280.170.090.110.10.93-0.110.190.220.15-0.14
0.13-0.46-0.03-0.380.6-0.310.13-0.350.06-0.120.27-0.280.00.25-0.09-0.10.170.28-0.370.41-0.230.0-0.050.08-0.05
0.770.29-0.010.620.10.790.55-0.26-0.680.740.240.75-0.420.28-0.090.340.790.70.70.49-0.170.660.860.28-0.34
0.310.540.220.07-0.130.440.290.11-0.380.440.160.27-0.270.17-0.10.340.320.360.540.23-0.340.390.480.24-0.28
0.730.370.050.650.010.720.44-0.1-0.490.630.050.75-0.270.090.170.790.320.90.730.43-0.160.480.640.1-0.18
0.710.280.310.520.140.730.48-0.08-0.30.640.080.72-0.040.110.280.70.360.90.620.44-0.160.290.57-0.060.02
0.630.820.250.87-0.40.760.370.14-0.490.620.050.77-0.260.1-0.370.70.540.730.620.270.160.430.610.08-0.16
0.83-0.090.130.190.710.250.42-0.84-0.290.530.910.24-0.180.930.410.490.230.430.440.27-0.180.30.390.17-0.17
-0.220.44-0.020.45-0.4-0.18-0.10.35-0.09-0.18-0.1-0.16-0.14-0.11-0.23-0.17-0.34-0.16-0.160.16-0.180.060.00.15-0.14
0.310.37-0.530.31-0.070.30.41-0.05-0.980.370.170.16-0.930.190.00.660.390.480.290.430.30.060.90.88-0.92
0.550.43-0.270.46-0.010.610.53-0.06-0.910.550.190.48-0.750.22-0.050.860.480.640.570.610.390.00.90.67-0.71
0.010.23-0.71-0.03-0.05-0.10.190.02-0.88-0.080.16-0.19-0.980.150.080.280.240.1-0.060.080.170.150.880.67-0.99
-0.03-0.280.7-0.050.090.04-0.23-0.030.91-0.02-0.140.150.98-0.14-0.05-0.34-0.28-0.180.02-0.16-0.17-0.14-0.92-0.71-0.99
Click cells to compare fundamentals

Cymat Technologies Account Relationship Matchups

Cymat Technologies fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.9M6.6M6.2M4.2M4.0M6.7M
Short Long Term Debt Total1.1M1.1M1.0M2.3M2.6M2.7M
Other Current Liab177.7K179.0K222.7K191.0K171.9K159.5K
Total Current Liabilities1.4M2.0M2.2M2.2M4.5M4.8M
Total Stockholder Equity(889.5K)2.9M2.3M(612.1K)(2.8M)(2.7M)
Property Plant And Equipment Net1.2M1.1M1.1M2.9M2.4M2.5M
Current Deferred Revenue62.7K182.3K390.8K240.2K276.2K140.7K
Net Debt810.4K(3.9M)(1.5M)2.0M986.4K1.0M
Retained Earnings(81.7M)(82.2M)(87.0M)(93.0M)(97.3M)(92.4M)
Accounts Payable1.0M1.5M1.4M1.5M2.1M1.1M
Cash251.6K5.0M2.5M324.0K56.3K53.5K
Non Current Assets Total1.2M1.1M1.4M2.9M2.4M4.7M
Cash And Short Term Investments251.6K5.0M2.5M324.0K291.6K277.1K
Net Receivables203.9K164.6K837.8K59.4K38.0K36.1K
Common Stock Shares Outstanding40.4M43.2M53.7M58.4M65.7M69.0M
Liabilities And Stockholders Equity1.9M6.6M6.2M4.2M3.7M6.9M
Non Current Liabilities Total1.4M1.7M1.7M2.6M2.2M1.2M
Inventory130.1K262.8K1.2M701.5K1.2M1.3M
Other Current Assets26.5K24.6K266.7K188.9K170.0K184.6K
Total Liab2.8M3.7M3.8M4.8M6.8M7.1M
Total Current Assets612.1K5.5M4.8M1.3M1.6M2.0M
Short Term Debt83.8K98.6K121.7K296.7K341.2K309.5K
Common Stock72.9M73.5M79.9M81.6M93.8M71.5M
Other Stockholder Equity7.8M7.9M9.3M10.6M9.6M9.1M
Other Liab414.0K748.5K783.8K581.3K668.5K525.3K
Net Tangible Assets(889.5K)2.9M2.3M(612.1K)(703.9K)(739.1K)
Property Plant Equipment1.2M1.1M1.1M2.9M3.3M3.4M
Net Invested Capital(889.5K)3.0M2.5M(469.2K)(1.8M)(1.7M)
Net Working Capital(747.2K)3.5M2.6M(934.6K)(3.0M)(2.8M)
Capital Stock72.9M73.5M79.9M81.6M83.2M84.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cymat Stock Analysis

When running Cymat Technologies' price analysis, check to measure Cymat Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cymat Technologies is operating at the current time. Most of Cymat Technologies' value examination focuses on studying past and present price action to predict the probability of Cymat Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cymat Technologies' price. Additionally, you may evaluate how the addition of Cymat Technologies to your portfolios can decrease your overall portfolio volatility.